🔎 Trials Near Me

Domov › BOPC › New York

Klinične študije za BOPC v New York

19 študij za BOPC išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Albany
  • Research Site, Massapequa
  • Research Site, New Windsor
  • in še 3
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Trinity Medical, WNY- Site Number : 8400157, Buffalo
  • Mid Hudson Medical Research - New Windsor- Site Number : 8400004, New Windsor
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • New York Hospital Queens- Site Number : 8400058, Flushing
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Mount Kisco
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Mount Sinai, Icahn School of Medicine, New York
  • Columbia University, New York
  • Cornell University, New York
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Staten Island
  • Research Site, Syracuse
  • Research Site, The Bronx
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Buffalo
  • Research Site, Cortland
  • Research Site, Horseheads
  • in še 2
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Northwell Health Physician Partners at Chappaqua, Chappaqua
  • New York Presbyterian Queens, Flushing
  • Northern Westchester Hospital, Mount Kisco
Vključevanje udeležencevFaza 2/3
Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

  • Equity Medical LLC, New York
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–80 · Vsi spoli · Posodobljeno 1. jul. 2026 · NCT06944925

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

  • Icahn School of Medicine at Mount Sinai, New York
Vključevanje udeležencev
Starost 22 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07222410

SPIROMICS Study of Early COPD Progression (SOURCE)

  • Columbia University, New York
  • Weill Cornell Medical Center, New York
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30–55 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05033990

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Mount Kisco
  • GSK Investigational Site, New Windsor
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06961214

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

  • New York University School of Medicine, New York
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT02779478

Lung Microbiome and Inflammation in Early COPD

  • New York University School of Medicine, New York
Vključevanje udeležencevOpazovalna študija
Starost 18–70 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT02777879

PiMZ Longitudinal Cohort (PiMZ Logic)

  • Columbia University Irving Medical Center, New York
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 16. jan. 2026 · NCT06505603

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

  • Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 14. nov. 2025 · NCT01776398

Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management

  • Ichan School of Medicine at Mount Sinai, New York
Vključevanje udeležencev
Starost 40 in več · Vsi spoli · Posodobljeno 6. okt. 2025 · NCT06634810

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Our Lady of Lourdes Hospital, Binghamton
Vključevanje udeležencevOpazovalna študija
Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

  • Mount Sinai, New York
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 12. okt. 2023 · NCT05306743

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.